Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radiotherapy Alone vs Radiotherapy Plus Goserelin and Cyproterone Acetate in High-Risk Prostate Cancer
NCT00849082Phase 3Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- May 1987
- Primary completion
- Nov 1995
- Modality
- Peptides, Orthosteric Ligands
01
Overview
A Phase 3 trial of goserelin, cyproterone in prostate cancer (PCa), sponsored by European Organisation for Research and Treatment of Cancer. Started May 1987; status: completed.
02
Drugs
goserelincyproterone
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00849082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00849082.